SCHEMBL25737005

SCHEMBL25737005

CCc1ccc(CC(=O)Nc2ccccc2)cc1

nearest known ligand 0.76

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EPHX2 P34913 1/20 0.76
MEN1 O00255 2/20 0.72
KMT2A Q03164 2/20 0.72
SMN1; SMN2 Q16637 3/20 0.67
LMNA P02545 1/20 0.67
RAB9A P51151 4/20 0.62
BCHE P06276 3/20 0.62
ACHE P22303 3/20 0.62
NPC1 O15118 2/20 0.62
HPGD P15428 1/20 0.60
RORC P51449 2/20 0.60
ALDH1A1 P00352 1/20 0.59
MAPT P10636 1/20 0.59
PRMT1 Q99873 1/20 0.57
GAA P10253 1/20 0.56
HDAC3 O15379 1/20 0.56
HDAC4 P56524 1/20 0.56
HDAC1 Q13547 1/20 0.56
HDAC7 Q8WUI4 1/20 0.56
HDAC2 Q92769 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10163448 0.95 EPHX2 (0.73) EPHX2MEN1KMT2ASMN1; SMN2LMNA
SCHEMBL10054999 0.91 EPHX2 (0.92) EPHX2MEN1KMT2ASMN1; SMN2RAB9A
SCHEMBL1516167 0.87 EPHX2 (1.00) EPHX2MEN1KMT2ASMN1; SMN2RAB9A
SCHEMBL9312345 0.86 EPHX2 (0.76) EPHX2MEN1KMT2ASMN1; SMN2RAB9A
Hydrochloric Acid SCHEMBL27735879 0.85 EPHX2 (0.96) EPHX2MEN1KMT2ASMN1; SMN2RAB9A
SCHEMBL3166771 0.84 SMN1; SMN2 (0.69) EPHX2MEN1KMT2ASMN1; SMN2LMNA
Toluene SCHEMBL11320238 0.84 EPHX2 (0.73) EPHX2MEN1KMT2ASMN1; SMN2RAB9A
SCHEMBL3714852 0.84 KMT2A (1.00) EPHX2MEN1KMT2ASMN1; SMN2LMNA
SCHEMBL4420808 0.84 EPHX2 (0.79) EPHX2MEN1KMT2ASMN1; SMN2RAB9A
SCHEMBL9845802 0.83 MEN1 (0.67) EPHX2MEN1KMT2ASMN1; SMN2RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240024490-A1 BIFUNCTIONAL MOLECULES FOR SELECTIVE MODIFICATION OF TARGET SUBSTRATES THE BROAD INSTITUTE, INC. 2024-01-25 US disclosed
US-20230192904-A1 BIFUNCTIONAL CHIMERIC MOLECULES FOR LABELING OF KINASES WITH TARGET BINDING MOIETIES AND METHODS OF USE THEREOF THE BROAD INSTITUTE, INC. 2023-06-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240024490-A1 BIFUNCTIONAL MOLECULES FOR SELECTIVE MODIFICATION OF TARGET SUBSTRATES COASY, JMJD7, PTMS EPHX2 584/4885MEN1 3675/4885KMT2A 2272/4885
US-20230192904-A1 BIFUNCTIONAL CHIMERIC MOLECULES FOR LABELING OF KINASES WITH TARGET BINDING MOIETIES AND METHODS OF USE THEREOF ERBB2, ACP1, TK1 EPHX2 941/4885MEN1 3627/4885KMT2A 1636/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.